Kevin Andres, MD
Pain Medicine · Elizabethtown, KYNPI 1033564166
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,596 of the $11,222 with a category attached, or 67.7%. 31 manufacturers reported payments, led by Medtronic at 24.3% of the total. Reporting peaked in 2022 at $3,970 and has fallen 55.9% since, to $1,750 in 2025.
Across 288 payments — averaging $38.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Spinal Simplicity, LLC$2K
- Saluda Medical Americas, Inc.$1K
- Abbott$719
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$551
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$250%
- Travel & lodging$3,60032%
- Food & beverage$7,59668%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 58 | $2,724 |
| Boston Scientific | 34 | $2,258 |
| Spinal Simplicity, LLC | 13 | $1,573 |
| Saluda Medical Americas, Inc. | 39 | $1,091 |
| Abbott | 14 | $719 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 44 | $551 |
| Nevro Corp. | 9 | $384 |
| Collegium Pharmaceutical, Inc. | 22 | $384 |
| Si-bone, Inc. | 8 | $311 |
| MML US, Inc. | 5 | $238 |
| Scilex Pharmaceuticals Inc. | 13 | $200 |
| Vertos Medical, Inc. | 2 | $170 |
| Tersera Therapeutics LLC | 1 | $127 |
| Merck | 3 | $53 |
| Azurity Pharmaceuticals, Inc. | 3 | $51 |
| ANI Pharmaceuticals, Inc. | 2 | $45 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Vertex | 2 | $33 |
| Curonix LLC | 2 | $30 |
| Averitas Pharma Inc. | 1 | $27 |
| Nalu Medical, Inc. | 1 | $25 |
| BD | 1 | $25 |
| Stryker | 1 | $25 |
| Amgen | 1 | $23 |
| Alpha Orthopedic Systems | 1 | $22 |
| AbbVie | 1 | $21 |
| Almatica Pharma LLC | 1 | $20 |
| Trevena, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion Indirect Decompression System$1,296
- HA MINUTEMAN G3-R$1,228
- KYPHON EXPRESS II KYPHOPAK TRAY$910
- INTELLIS ADAPTIVESTIM$497
- Intracept$251
- Proclaim IPG$250
- mild Device Kit$148
- Evoke SCS$145
- WaveWriter Alpha Prime 16$137
- PRIALT$127
- PROCLAIM$124
- Senza II$123
- Evoke$121
- GENERAL PAIN MANAGEMENT$117
- Senza$109
- ETERNA$101
How this compares
$11,222 in reported general payments places this provider in the 75th percentile of 90 pain medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 3,547 | $102,236 |
| OxycontinOxycodone Hcl | 68 | $39,874 |
| Oxycodone Hcl | 830 | $21,890 |
| Xtampza ErOxycodone Myristate | 22 | $21,387 |
| Pregabalin | 491 | $18,464 |
| Gabapentin | 1,668 | $17,121 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 778 | $17,054 |
| NucyntaTapentadol Hcl | 21 | $16,840 |
| MovantikNaloxegol Oxalate | 31 | $14,388 |
| ZtlidoLidocaine | 12 | $13,724 |
| Lidocaine | 55 | $6,324 |
| NeurontinGabapentin | 12 | $5,811 |
| Morphine Sulfate ErMorphine Sulfate | 144 | $3,874 |
| Fentanyl | 28 | $3,815 |
| Methadone Hcl | 162 | $3,470 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta | $384 | $38,22743 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $200 | $13,72412 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $15 | $57415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 90 pain medicine providers in Kentucky.
Other pain medicine in Elizabethtown
- Christopher AndersonElizabethtown$6K
- Jenna Dismore WrinklesElizabethtown$5K
- Anjum BuxDanville$595K
- Christopher MallardLexington$47K
- Vinod MuniswamyGeorgetown$39K
- John RuxerPaducah$33K
- Timothy BeachamLouisville$31K
- Mazhar RasulLexington$30K
- Tejas ShahAshland$23K
- Lance HoffmanFlorence$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.